ProCE Banner Activity

Using New Therapies for Moderate to Severe Atopic Dermatitis: A Quick Guide

PDF

A quick reference guide on recent advances in the management of moderate to severe atopic dermatitis

Released: February 20, 2023

Expiration: February 19, 2024

No longer available for credit.

Share

Faculty

Robert Sidbury

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Jonathan Silverberg

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Sanofi Genzyme

Faculty Disclosure

Primary Author

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Robert Sidbury, MD, MPH: consultant/advisor/speaker: Beiersdorf, Leo, Lilly, Micreos; researcher: Castle, Galderma, Pfizer, Regeneron, UCB.

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Jonathan Silverberg, MD: consultant/advisor: AbbVie, Aobiome, Arcutis, Amgen, Arena, Asana, Aslan, BioMX, Biosion, Bodewell, Boehringer Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo, Lilly, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron, Sanofi, Shaperon, Union.